Remedica issues voluntary recall for Remethan 100mg

Pharmaceutical company Remedica Limited has issued a reminder regarding the ongoing voluntary recall of specific batches of the anti-inflammatory drug Remethan 100mg prolonged-release tablets. This announcement serves as a follow-up to the initial notification issued on July 1, 2026. Patients currently using this medication are advised to stop taking it immediately and consult their doctor or pharmacist to discuss alternative treatments. Affected batches include 98462, 102141, 103797, 105515, 106374, 107171, 107818, 108262, 111115, 113029, 115344, 116856, 118658, 122934, and 127806. Consumers should check the expiration dates and batch numbers on their packaging to ensure safety. The company specifically noted that batches 116856, 122934, and 127806 may still be available on the market. All recalled products should be returned to the pharmacy where they were purchased.